Latest / The Deal by S&P Global
Activist Investing Today: Eldar on Anti-Activist Pill Evolution
When corporations install anti-activist poison pills they are less likely to implement new share buybacks and their operationally-focused capital expenditures tend to be higher, UC Berkeley School of Law professor Ofer Eldar explains.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.